Purpose: To evaluate the IOP-lowering efficacy of bimatoprost and travoprost for the treatment of glaucoma and ocular hypertension. Methods: Randomized, double-masked, parallel-group clinical trial. After completing a...Purpose: To evaluate the IOP-lowering efficacy of bimatoprost and travoprost for the treatment of glaucoma and ocular hypertension. Methods: Randomized, double-masked, parallel-group clinical trial. After completing a washout from all glaucoma medications, patients (n =27) were randomized to bimatoprost or travoprost for 6 months. Visits were at baseline, week 1,展开更多
文摘Purpose: To evaluate the IOP-lowering efficacy of bimatoprost and travoprost for the treatment of glaucoma and ocular hypertension. Methods: Randomized, double-masked, parallel-group clinical trial. After completing a washout from all glaucoma medications, patients (n =27) were randomized to bimatoprost or travoprost for 6 months. Visits were at baseline, week 1,
